0001209191-22-043290.txt : 20220727
0001209191-22-043290.hdr.sgml : 20220727
20220727182244
ACCESSION NUMBER: 0001209191-22-043290
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220725
FILED AS OF DATE: 20220727
DATE AS OF CHANGE: 20220727
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Al-Wakeel Yasir B.
CENTRAL INDEX KEY: 0001650691
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39592
FILM NUMBER: 221112228
MAIL ADDRESS:
STREET 1: MERRIMACK PHARMACEUTICALS, INC.
STREET 2: ONE KENDALL SQUARE, SUITE B7201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kronos Bio, Inc.
CENTRAL INDEX KEY: 0001741830
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1300 S. EL CAMINO REAL
STREET 2: SUITE 400
CITY: SAN MATEO
STATE: CA
ZIP: 94402
BUSINESS PHONE: 212-871-7920
MAIL ADDRESS:
STREET 1: 1300 S. EL CAMINO REAL
STREET 2: SUITE 400
CITY: SAN MATEO
STATE: CA
ZIP: 94402
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-07-25
0
0001741830
Kronos Bio, Inc.
KRON
0001650691
Al-Wakeel Yasir B.
C/O KRONOS BIO, INC.
1300 SO. EL CAMINO REAL, SUITE 300
SAN MATEO
CA
94402
0
1
0
0
Chief Financial Officer
Common Stock
2022-07-25
4
A
0
53600
0.00
A
216841
D
Employee Stock Option (Right to Buy)
5.02
2022-07-25
4
A
0
40000
0.00
A
2032-07-24
Common Stock
40000
40000
D
50% of the shares subject to the stock option shall vest and become exercisable on June 30, 2023 and the remaining shares shall vest and become exercisable on December 31, 2023.
/s/ Allison Frisbee, Attorney-in-Fact
2022-07-27